Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2579-2585

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duan, J.
Right arrow Articles by Imaizumi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duan, J.
Right arrow Articles by Imaizumi, T.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Angiogenesis
Right arrow Animal models of human disease
Right arrow Risk Factors
Right arrow Ischemic biology - basic studies
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2579.)
© 2000 American Heart Association, Inc.


Vascular Biology

Hyperhomocysteinemia Impairs Angiogenesis in Response to Hindlimb Ischemia

Junli Duan; Toyoaki Murohara; Hisao Ikeda; Ken-ichiro Sasaki; Satoshi Shintani; Takako Akita; Toshifumi Shimada; Tsutomu Imaizumi

From The Cardiovascular Research Institute and Department of Internal Medicine III, Kurume University School of Medicine, Kurume, Japan.

Correspondence to Toyoaki Murohara, MD, PhD, The Cardiovascular Research Institute, Kurume University, 67 Asahi-machi, Kurume, 830-0011 Japan. E-mail toyom{at}med.kurume-u.ac.jp

Abstract—Hyperhomocysteinemia (HH) is an independent risk factor for atherosclerosis, including peripheral arterial occlusive disease (PAOD). Because angiogenesis and collateral vessel formation are important self-salvage mechanisms for ischemic PAOD, we examined whether HH modulates angiogenesis in vivo in a rat model of hindlimb ischemia. Rats were divided into 3 groups: the control group was given tap water, the HH group was given water containing l-methionine (1 g · kg-1 · d-1), and the HH+L-arg group was given water containing methionine (1 g · kg-1 · d-1) and l-arginine (2.25 vol%). At day 14 of the dietary modifications, the left femoral artery and vein were excised, and the extent of angiogenesis and collateral vessels in the ischemic limb were examined for 4 weeks. Plasma homocysteine levels significantly increased (P<0.001), and plasma and tissue contents of nitrite+nitrate as well as tissue cGMP levels significantly decreased in the HH group compared with the control group (P<0.01). Laser Doppler blood flowmetry (LDBF) revealed a significant decrease in the ischemic/normal limb LDBF ratio in the HH group at days 7, 14, 21, and 28 (P<0.01 versus control). Angiography revealed a significant decrease in the angiographic score in the HH group at day 14 (P<0.001 versus control). Immunohistochemistry of ischemic tissue sections showed a significant reduction in the capillary density in the HH group (P<0.001 versus control). Oral l-arginine supplementation in rats with HH (HH+L-arg) restored the decreased plasma and tissue nitrite+nitrate and cGMP contents (P<0.05) as well as angiogenesis, as assessed by LDBF (P<0.05 versus HH), angiographic score (P<0.01 versus HH), and capillary density (P<0.001 versus HH). In summary, HH impaired ischemia-induced angiogenesis and collateral vessel formation in a rat model of hindlimb ischemia in vivo. The mechanism of the HH-induced impairment of angiogenesis might be mediated in part by a reduced bioactivity of endogenous NO in the HH state.


Key Words: endothelium • homocysteine • nitric oxide • peripheral artery disease • risk factors




This article has been cited by other articles:


Home page
Circ. Res.Home page
S. H. Schirmer, J. O. Fledderus, P. T.G. Bot, P. D. Moerland, I. E. Hoefer, J. Baan Jr, J. P.S. Henriques, R. J. van der Schaaf, M. M. Vis, A. J.G. Horrevoets, et al.
Interferon-{beta} Signaling Is Enhanced in Patients With Insufficient Coronary Collateral Artery Development and Inhibits Arteriogenesis in Mice
Circ. Res., May 23, 2008; 102(10): 1286 - 1294.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. A. Medina
Hyperhomocysteinemia and Occlusive Vascular Disease: An Emergent Role for Fibroblast Growth Factor 2
Circ. Res., April 25, 2008; 102(8): 869 - 870.
[Full Text] [PDF]


Home page
Circ. Res.Home page
P.-Y. Chang, S.-C. Lu, C.-M. Lee, Y.-J. Chen, T. A. Dugan, W.-H. Huang, S.-F. Chang, W. S.L. Liao, C.-H. Chen, and Y.-T. Lee
Homocysteine Inhibits Arterial Endothelial Cell Growth Through Transcriptional Downregulation of Fibroblast Growth Factor-2 Involving G Protein and DNA Methylation
Circ. Res., April 25, 2008; 102(8): 933 - 941.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
I. Penuelas, X. L. Aranguren, G. Abizanda, J. M. Marti-Climent, M. Uriz, M. Ecay, M. Collantes, G. Quincoces, J. A. Richter, and F. Prosper
13N-Ammonia PET as a Measurement of Hindlimb Perfusion in a Mouse Model of Peripheral Artery Occlusive Disease
J. Nucl. Med., July 1, 2007; 48(7): 1216 - 1223.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Simons
Angiogenesis: Where Do We Stand Now?
Circulation, March 29, 2005; 111(12): 1556 - 1566.
[Full Text] [PDF]


Home page
Vasc MedHome page
M. Bosch-Marce, R. Pola, A. B Wecker, M. Silver, A. Weber, C. Luedemann, C. Curry, T. Murayama, M. Kearney, Y.-s. Yoon, et al.
Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia
Vascular Medicine, February 1, 2005; 10(1): 15 - 22.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
K.-i. Sasaki, J. Duan, T. Murohara, H. Ikeda, S. Shintani, T. Shimada, T. Akita, K. Egami, and T. Imaizumi
Rescue of hypercholesterolemia-related impairment of angiogenesis by oral folate supplementation
J. Am. Coll. Cardiol., July 16, 2003; 42(2): 364 - 372.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Pipp, M. Heil, K. Issbrucker, T. Ziegelhoeffer, S. Martin, J. van den Heuvel, H. Weich, B. Fernandez, G. Golomb, P. Carmeliet, et al.
VEGFR-1-Selective VEGF Homologue PlGF Is Arteriogenic: Evidence for a Monocyte-Mediated Mechanism
Circ. Res., March 7, 2003; 92(4): 378 - 385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. J. Hunt and S. C. Tyagi
Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation
Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1073 - C1079.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Vallee, F. Guay, D. Beaudry, J. Matte, R. Blouin, J.-P. Laforest, M. Lessard, and M.-F. Palin
Effects of Breed, Parity, and Folic Acid Supplement on the Expression of Folate Metabolism Genes in Endometrial and Embryonic Tissues from Sows in Early Pregnancy
Biol Reprod, October 1, 2002; 67(4): 1259 - 1267.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. E. Hoefer, N. van Royen, J. E. Rectenwald, E. J. Bray, Z. Abouhamze, L. L. Moldawer, M. Voskuil, J. J. Piek, I. R. Buschmann, and C. K. Ozaki
Direct Evidence for Tumor Necrosis Factor-{alpha} Signaling in Arteriogenesis
Circulation, April 9, 2002; 105(14): 1639 - 1641.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. Bagi, Z. Ungvari, and A. Koller
Xanthine Oxidase-Derived Reactive Oxygen Species Convert Flow-Induced Arteriolar Dilation to Constriction in Hyperhomocysteinemia: Possible Role of Peroxynitrite
Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 28 - 33.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. S. Mujumdar, C. M. Tummalapalli, G. M. Aru, and S. C. Tyagi
Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR
Am J Physiol Cell Physiol, May 1, 2002; 282(5): C1009 - C1015.
[Abstract] [Full Text] [PDF]